Developmental increase in expression of the messenger ribonucleic acid and protein levels of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 in the baboon placenta

被引:50
|
作者
Pepe, GJ
Babischkin, JS
Burch, MG
Leavitt, MG
Albrecht, ED
机构
[1] UNIV MARYLAND, SCH MED, CTR STUDIES REPROD, DEPT OBSTET GYNECOL, BALTIMORE, MD 21201 USA
[2] UNIV MARYLAND, SCH MED, CTR STUDIES REPROD, DEPT PHYSIOL, BALTIMORE, MD 21201 USA
关键词
D O I
10.1210/en.137.12.5678
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cortisol-cortisone interconversion is catalyzed by the NADP/NADPH-dependent oxido-reductase, 11 beta-hydroxysteroid dehydrogenase-1 (11 beta HSD-1) and the NAD-dependent oxidase, 11 beta HSD-2. Because of the importance of placental corticosteroid metabolism in dictating the amount of cortisol arriving in the fetus to regulate fetal pituitary-adrenocortical function, the present study determined whether there was a developmental change in the expression of 11 beta HSD-1 and/or -2 in placental syncytiotrophoblast, the site of maternal:fetal exchange. A syncytiotrophoblast-enriched (>95%) cell fraction was isolated from baboon placentas obtained at early (day 60), mid (day 100), and late (day 165) gestation (term = day 184), and 11 beta HSD-1 and -2 messenger RNA (mRNA) and protein levels were determined by Northern and Western blots. The levels (mean +/- se) of the single 1.6-kilobase (kb) mRNA for 11 beta HSD-1, expressed as a ratio to beta-actin, increased (P < 0.05) between early (0.36 +/- 0.16; n = 4) and mid (0.95 +/- 0.21; n = 11) gestation and further increased (P < 0.05) by late gestation (1.82 +/- 0.29; n = 13). Similarly, the levels of the single 1.9-kb mRNA for 11 beta HSD-2 in late gestation (2.46 +/- 0.35; n = 8) were greater (P < 0.05) than respective values at mid (1.36 +/- 0.22; n = 8) and early (0.64; n = 2) gestation. The levels of 11 beta HSD-1 (arbitrary densitometric units), detected as a dominant band of 34 kDa, were greater (P < 0.05) in late gestation (2.6 +/- 0.2; n = 4) than at early (1.2 +/- 0.1; n = 4) or mid (1.9 +/- 0.3; n = 4) gestation. In contrast, 11 beta HSD-2 was not detected by Western blot in syncytiotrophoblast isolated by collagenase dispersion. However, immunocytochemistry revealed that 11 beta HSD-2 was present in and localized to the syncytiotrophoblast layer of the baboon placenta and that expression in late gestation (n = 4) appeared to exceed that in placentas of early (n = 4) and mid (n = 4) gestation. These results indicate that both 11 beta HSD-1 and 11 beta HSD-2 were expressed in syncytiotrophoblasts of the baboon placenta and that the mRNA and protein levels of these two 11 beta HSD enzymes increased with advancing gestation. However, because 11 beta HSD-2 was not detected in syncytiotrophoblast isolated by collagenase dispersion, we suggest that the 11 beta HSD-1 and -2 reside in different membrane fractions of the syncytiotrophoblast. Consequently, the estrogen-regulated change in transplacental cortisol metabolism with advancing gestation may result in a developmental change in the expression and location of the two 11 beta HSD enzymes controlling cortisol-cortisone metabolism and transfer into the fetus, resulting in activation of the fetal pituitary adrenocortical system.
引用
收藏
页码:5678 / 5684
页数:7
相关论文
共 50 条
  • [41] Hippocampal 11β-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese Zucker rat
    Buren, Jonas
    Bergstrom, Sven-Anders
    Loh, Edmund
    Soderstrom, Ingegerd
    Olsson, Tommy
    Mattsson, Cecilia
    ENDOCRINOLOGY, 2007, 148 (06) : 2716 - 2722
  • [42] EXPRESSION OF PIT-1 MESSENGER-RIBONUCLEIC-ACID AND PROTEIN IN THE HUMAN PLACENTA
    BAMBERGER, AM
    BAMBERGER, CM
    PU, LP
    PUY, LA
    LOH, YP
    ASA, SL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07): : 2021 - 2026
  • [43] Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver
    Moghrabi, N
    Head, JR
    Andersson, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11): : 3872 - 3878
  • [44] Differential expression of nuclear 11 beta-hydroxysteroid dehydrogenase type 2 in mineralocorticoid receptor positive and negative tissues
    Petrelli, MD
    LimTio, SS
    Condon, J
    Hewison, M
    Stewart, PM
    ENDOCRINOLOGY, 1997, 138 (07) : 3077 - 3080
  • [45] Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians
    Lindsay, RS
    Wake, DJ
    Nair, S
    Bunt, J
    Livingstone, DEW
    Permana, PA
    Tataranni, PA
    Walker, BR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06): : 2738 - 2744
  • [46] Developmental regulation of vascular endothelial growth/permeability factor messenger ribonucleic acid levels in and vascularization of the villous placenta during baboon pregnancy
    Hildebrandt, VA
    Babischkin, JS
    Koos, RD
    Pepe, GJ
    Albrecht, ED
    ENDOCRINOLOGY, 2001, 142 (05) : 2050 - 2057
  • [47] Developmental expression of and effect of betamethasone on the messenger ribonucleic acid levels for peptide growth factors in the baboon fetal adrenal gland
    Aberdeen, GW
    Pepe, GJ
    Albrecht, ED
    JOURNAL OF ENDOCRINOLOGY, 1999, 163 (01) : 123 - 130
  • [48] Type II 11 beta-hydroxysteroid dehydrogenase (11BHSD2) expression and activity in the human adrenal cortex (ADC)
    Mazzocchi, G
    Rossi, GP
    Neri, G
    Malendowicz, LK
    Albertin, G
    Nussdorfer, GG
    JOURNAL OF HYPERTENSION, 1998, 16 : S59 - S59
  • [49] Testosterone decreases 3 beta-hydroxysteroid dehydrogenase-isomerase messenger ribonucleic acid in cultured mouse Leydig cells by a strain-specific mechanism
    Heggland, SJ
    Signs, SA
    Stalvey, JRD
    JOURNAL OF ANDROLOGY, 1997, 18 (06): : 646 - 655
  • [50] Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: Oxidation reduction and inhibition
    LuuThe, V
    Zhang, Y
    Poirier, D
    Labrie, F
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 55 (5-6): : 581 - 587